Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-01-25
2009-02-17
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S212060, C514S218000, C514S318000, C514S326000, C540S488000, C540S492000, C540S524000, C546S193000, C546S208000, C546S210000
Reexamination Certificate
active
07491713
ABSTRACT:
Compounds of Formula I:and Formula II:(where variables R1, R2, R3, R4, A, B, D, G, J, Q, T, W, X and Y are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, pharmaceutical compositions comprising these compounds, use of these compounds and compositions to prevent or treat diseases involving CGRP.
Burgey Christopher S.
Paone Daniel V.
Shaw Anthony W
Stump Craig A.
Williams Theresa M.
Kifle Bruck
Krovatin William
Merck & Co. , Inc.
Todaro John
LandOfFree
CGRP receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CGRP receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CGRP receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4119224